PASG- Passage Bio, Inc.

Name: Passage Bio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Passage Bio, Inc. (PASG) has 4 insiders with recent SEC Form 4 filings, including 4 buys and 13 sells. PASG is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Orbimed Advisors LLC	6.07M	$33.91M	-
10%	Lynx1 Capital Management LP	623.7K	$3.49M	-
CEO	Chou William	10.6K	$59.3K	-
CFO	Borthwick Kathleen	7.5K	$41.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 27, 2024	Lynx1 Capital Management LP45	10% Owner	Buy	373,645	$0.65	$241,038.39	+4.2%	-37.1%	-17.4%
Dec 20, 2024	Orbimed Advisors LLC67	10% Owner	Sell	230,321	$0.60	$138,192.60	-3.0%	-27.9%	-27.3%
Dec 11, 2024	Orbimed Advisors LLC67	10% Owner	Sell	62,276	$0.83	$51,988.04	-0.3%	-45.5%	-29.6%
Dec 6, 2024	Orbimed Advisors LLC67	10% Owner	Sell	97,103	$0.80	$77,338.46	-0.6%	-39.4%	-40.6%
Nov 27, 2024	Lynx1 Capital Management LP45	10% Owner	Buy	456,353	$0.62	$284,519.51	+1.8%	-20.9%	-33.8%
Sep 19, 2024	Orbimed Advisors LLC67	10% Owner	Sell	39,300	$0.71	$27,903.00	-0.5%	-12.6%	-48.8%
Sep 18, 2024	Orbimed Advisors LLC67	10% Owner	Sell	200,131	$0.73	$146,726.63	-0.8%	-4.4%	-46.1%
Feb 13, 2024	Borthwick Kathleen62	SVP, Interim CFO	Sale+OE	1,470	$0.97	$1,425.90	-4.9%	+49.5%	-47.5%
Feb 13, 2024	Forman Mark S	Chief Medical Officer	Sale+OE	1,638	$0.97	$1,588.86	-3.3%	+49.5%	-47.5%
Jan 2, 2024	Forman Mark S	Chief Medical Officer	Sale+OE	15,813	$0.91	$14,389.83	-25.9%	+52.0%	-7.9%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC